Phocas Financial Corp. Ani Pharmaceuticals Inc Transaction History

Phocas Financial Corp.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$50.28 - $64.61 $3,620 - $4,651	-72 Reduced 0.1%	75,213 $4.37 Million
Q2 2023 Jul 12, 2023	SELL	$37.29 - $53.83 $15,624 - $22,554	-419 Reduced 0.55%	75,285 $4.05 Million
Q1 2023 Apr 13, 2023	BUY	$37.61 - $45.72 $2.85 Million - $3.46 Million	75,704 New	75,704 $3.01 Million
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $3.08 Million - $6.82 Million	-101,567 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $1.43 Million - $2.05 Million	-25,633 Reduced 20.15%	101,567 $6.26 Million
Q3 2019 Nov 15, 2019	SELL	$64.7 - $85.39 $12,357 - $16,309	-191 Reduced 0.15%	127,200 $9.27 Million
Q2 2019 Aug 16, 2019	SELL	$67.77 - $82.2 $920,723 - $1.12 Million	-13,586 Reduced 9.64%	127,391 $0
Q1 2019 May 13, 2019	BUY	$45.83 - $70.54 $527,090 - $811,280	11,501 Added 8.88%	140,977 $9.95 Million
Q4 2018 Feb 15, 2019	BUY	$41.17 - $56.44 $1.35 Million - $1.84 Million	32,671 Added 33.75%	129,476 $5.83 Million
Q3 2018 Nov 15, 2018	BUY	$52.95 - $71.34 $2.92 Million - $3.93 Million	55,064 Added 131.92%	96,805 $5.47 Million
Q2 2018 Aug 15, 2018	BUY	$56.38 - $68.08 $2.35 Million - $2.84 Million	41,741 New	41,741 $2.79 Million

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.